| Literature DB >> 23051667 |
Yuliaxis Ramayo-Caldas1, Nuria Mach, Anna Esteve-Codina, Jordi Corominas, Anna Castelló, Maria Ballester, Jordi Estellé, Noelia Ibáñez-Escriche, Ana I Fernández, Miguel Pérez-Enciso, Josep M Folch.
Abstract
BACKGROUND: New advances in high-throughput technologies have allowed for the massive analysis of genomic data, providing new opportunities for the characterization of the transcriptome architectures. Recent studies in pigs have employed RNA-Seq to explore the transcriptome of different tissues in a reduced number of animals. The main goal of this study was the identification of differentially-expressed genes in the liver of Iberian x Landrace crossbred pigs showing extreme phenotypes for intramuscular fatty acid composition using RNA-Seq.Entities:
Mesh:
Substances:
Year: 2012 PMID: 23051667 PMCID: PMC3478172 DOI: 10.1186/1471-2164-13-547
Source DB: PubMed Journal: BMC Genomics ISSN: 1471-2164 Impact factor: 3.969
Figure 1Graphical representation of the first and second principal components summarizing the phenotype variation of traits related to carcass quality and intramuscular fatty acid composition. Low group (L) animals are indicated with green triangles and High (H) animals with red triangles, while blue squares represent the whole populations. The ten sequenced animals are represented with circles containing asterisks. Abbreviations are defined in Table 1.
Mean comparison ± standard deviation between high and low groups for the traits included in the principal components analysis (PCA)
| Carcass height (CH) | 72.79 ± 9.90 | 69.57 ± 12.73 | NS |
| Weight of ham (WH) | 19.88 ± 2.46 | 19.66 ± 3.10 | NS |
| Weight of Shoulder (WS) | 10.26 ± 1.25 | 10.93 ± 2.10 | NS |
| Intramuscular fat (IMF) | 2.21 ± 0.88 | 1.49 ± 0.38 | NS |
| | | | |
| | | | |
| Myristic acid (C14:0) | 1.22 ± 0.13 | 1.12 ± 0.12 | NS |
| Palmitic acid (C16:0) | 23.78 ± 0.79 | 21.39 ± 0.69 | *** |
| Heptadecanoic acid (C17:0) | 0.20 ± 0.03 | 0.33 ± 0.09 | *** |
| Stearic acid (C18:0) | 14.65 ± 1.16 | 13.69 ± 0.77 | * |
| Arachidic acid (C20:0) | 0.26 ± 0.05 | 0.21 ± 0.08 | NS |
| | | | |
| Palmitoleic acid (C16:1 n-7) | 2.74 ± 0.24 | 2.20 ± 0.33 | *** |
| Heptadecenoic acid (C17:1) | 0.20 ± 0.05 | 0.32 ± 0.20 | ** |
| Oleic acid (C18:1 n-9) | 42.57 ± 1.34 | 34.92 ± 2.96 | *** |
| Octadecenoic acid (C18:1 n-9) | 4.04 ± 0.27 | 3.70 ± 0.31 | * |
| Eicosenoic acid (C20:1 n-9) | 0.86 ± 0.08 | 0.77 ± 0.07 | NS |
| | | | |
| Linoleic acid (C18:2 n-6) | 7.16 ± 0.52 | 15.11 ± 1.65 | *** |
| α-Linolenic acid (C18:2 n-3) | 0.46 ± 0.08 | 1.10 ± 0.56 | *** |
| Eicosadienoic acid (C20:2 n-6) | 0.41 ± 0.05 | 0.63 ± 0.13 | *** |
| Eicosatrienoic acid (C20:3 n-6) | 0.16 ± 0.03 | 0.53 ± 0.15 | *** |
| Arachidonic acid (C20:4 n-6) | 0.84 ± 0.17 | 3.10 ± 0.77 | *** |
| | | | |
| Average Chain Length (ACL) | 17.44 ± 0.02 | 17.49 ± 0.12 | * |
| Saturated FA (SFA) | 40.12 ± 1.51 | 36.72 ± 1.22 | *** |
| Monounsaturated FA (MUFA) | 50.72 ± 1.56 | 42.38 ± 3.13 | *** |
| Polyunsaturated FA (PUFA) | 9.03 ± 0.64 | 20.46 ± 2.21 | *** |
| Peroxidability index (PI) | 12.28 ± 3.80 | 32.43 ± 4.43 | *** |
| Double-bond index (DBI) | 0.65 ± 0.20 | 0.91 ± 0.03 | *** |
| Unsaturated index (UI) | 1.63 ± 0.50 | 2.48 ± 0.10 | *** |
NS: p-value > 0.05, * p-value < 0.05, ** p-value < 0.01, *** p-value < 0.001.
Number of single-end 100 bp reads obtained and percentages of mapped reads per animal
| L1 | 9.87 | 7.28 | 73.82 |
| L2 | 12.44 | 8.88 | 71.42 |
| L3 | 13.98 | 10.62 | 75.95 |
| L4 | 11.15 | 8.47 | 75.96 |
| L5 | 14.42 | 11.21 | 77.75 |
| H1 | 16.05 | 12.43 | 77.45 |
| H2 | 12.57 | 9.77 | 77.68 |
| H3 | 14 | 10.75 | 76.77 |
| H4 | 14.94 | 11.52 | 77.14 |
| H5 | 17.23 | 13.1 | 76.03 |
| 136.65 | 104.03 | 76.13 |
1 L1 to L5 and H1 to H5 correspond to animals of the L and H groups, respectively.
2 Indicate millions of reads.
Proportion of reads mapping to exons, introns or within 1 Kb upstream or downstream of the annotated genes
| L1 | 60.44 | 16.44 | 5.03 |
| L2 | 66.48 | 13.59 | 4.06 |
| L3 | 65.52 | 13.06 | 5.31 |
| L4 | 63.35 | 14.71 | 4.57 |
| L5 | 62.86 | 12.71 | 4.6 |
| H1 | 63.54 | 13.52 | 5.44 |
| H2 | 62.1 | 15.08 | 4.78 |
| H3 | 64.87 | 14.11 | 4.28 |
| H4 | 65.95 | 11.12 | 5.46 |
| H5 | 66.46 | 12.98 | 4.44 |
1 L1 to L5 and H1 to H5 correspond to animals of the L and H groups, respectively.
2 Reads located either 1 Kb upstream or downstream of the annotated genes.
Number of transcripts assembled (TA) with Cufflinks and the percentage they represent in each sample
| = | 1971 | 8.7 | 2486 | 10.4 | 2526 | 11 | 2244 | 9.2 | 2762 | 10.2 | 2642 | 10.1 | 2363 | 9.4 | 2761 | 9.9 | 2119 | 10.4 | 2838 | 10.5 |
| c | 4059 | 17.8 | 4202 | 17.6 | 3953 | 17.2 | 4203 | 17.3 | 4289 | 15.9 | 3955 | 15.1 | 4083 | 16.3 | 4183 | 15.0 | 3569 | 17.5 | 3961 | 14.7 |
| e | 745 | 3.3 | 508 | 2.1 | 518 | 2.3 | 672 | 2.8 | 576 | 2.1 | 616 | 2.4 | 736 | 2.9 | 604 | 2.2 | 489 | 2.4 | 529 | 2.0 |
| i | 3115 | 13.7 | 2719 | 11.4 | 2629 | 11.4 | 3153 | 13.0 | 3248 | 12.0 | 3301 | 12.6 | 3373 | 13.5 | 3637 | 13.1 | 2250 | 11.0 | 3234 | 12.0 |
| j | 4348 | 19.1 | 4709 | 19.7 | 4436 | 19.3 | 4666 | 19.2 | 5373 | 19.9 | 5288 | 20.2 | 4833 | 19.3 | 5658 | 20.3 | 3488 | 17.1 | 5428 | 20.1 |
| o | 1067 | 4.7 | 1175 | 4.9 | 1139 | 5.0 | 1157 | 4.8 | 1237 | 4.6 | 1142 | 4.4 | 1154 | 4.6 | 1170 | 4.2 | 1129 | 5.5 | 1204 | 4.5 |
| p | 1570 | 6.9 | 1656 | 6.9 | 1566 | 6.8 | 1682 | 6.9 | 1635 | 6.1 | 1603 | 6.1 | 1606 | 6.4 | 1676 | 6.0 | 1699 | 8.3 | 1598 | 5.9 |
| s | 60 | 0.3 | 77 | 0.3 | 72 | 0.3 | 76 | 0.3 | 94 | 0.4 | 86 | 0.3 | 71 | 0.3 | 72 | 0.3 | 68 | 0.3 | 100 | 0.4 |
| u | 4447 | 19.5 | 4560 | 19.1 | 4541 | 19.7 | 4789 | 19.7 | 5468 | 20.2 | 5456 | 20.9 | 5089 | 20.3 | 5680 | 20.4 | 4421 | 21.7 | 5638 | 20.9 |
| x | 1392 | 6.1 | 1838 | 7.7 | 1630 | 7.1 | 1663 | 6.8 | 2346 | 8.7 | 2066 | 7.9 | 1761 | 7.0 | 2415 | 8.7 | 1192 | 5.8 | 2496 | 9.2 |
| 22774 | 100 | 23930 | 100 | 23010 | 100 | 24305 | 100 | 27028 | 100 | 26155 | 100 | 25069 | 100 | 27856 | 100 | 20424 | 100 | 27026 | 100 | |
Class codes described by Cuffcompare: "=" Exactly equal to the reference annotation, "c " Contained in the reference annotation, "e" possible pre-mRNA molecule, "i " An exon falling into an intron of the reference, "j " New isoforms, "o" Unknown, generic overlap with reference, "p" Possible polymerase run-on fragment, “s” An intron of the transfrag overlapping a reference intron on the opposite strand, "u" Unknown, intergenic transcript, “x” Exonic overlap with reference on the opposite strand. L1 to L5 and H1 to H5 correspond to animals of the L and H groups, respectively.
Putative proteins identified in each H and L groups and orthologies detected against, and protein databases
| 146 | 110 | 114 | 50 | 82 | |
| 180 | 133 | 135 | 59 | 104 |
Predicted proteins reported in pigs by Esteve-Codina et al., (2011) are also included.
Figure 2Q-Q plot representing the distribution of the p-value. Red line represents the expected distribution of the p-value, while blue trend represents the observed distribution. X-axis values are Expected -log10 (p-value) and y-axis values are the Observed –log 10 (p-value).
Figure 3Plot of the 55 differentially-expressed protein-coding genes (represented in blue) with fold change ≥ 1.5 and p-value ≤ 0.005. X-axis values are base mean expression values and y-axis values are the log2 (fold change).
Description of the differentially-expressed genes detected between High and Low groups with fold change ≥ 1.5 and p-value ≤0.005
| ENSSSCG00000010610 | GSTO1 | 3.8 | 1.1 x 10-16 | 2.2x10-13 | protein_coding |
| ENSSSCG00000010992 | AQP7 | −6.7 | 3.0 x 10-13 | 2.9 x 10-10 | protein_coding |
| ENSSSCG00000016401 | KIF1A | −12.5 | 2.2 x 10-11 | 1.4 x 10-8 | protein_coding |
| ENSSSCG00000010488 | CYP2C9 | 2.5 | 1.3 x 10-8 | 6.3 x 10-6 | protein_coding |
| ENSSSCG00000013865 | NWD1 | 16.2 | 5.2 x 10-7 | 2.0 x 10-4 | protein_coding |
| ENSSSCG00000012015 | C21orf91 | 20.4 | 1.0 x 10-6 | 3.0 x 10-4 | protein_coding |
| ENSSSCG00000007873 | -- | −3.7 | 1.4 x 10-6 | 4.0 x 10-4 | protein_coding |
| ENSSSCG00000009871 | SDS | 2.2 | 7.8 x 10-6 | 2.0 x 10-3 | protein_coding |
| ENSSSCG00000002383 | FOS | −2.0 | 1.3 x 10-5 | 3.0 x 10-3 | protein_coding |
| ENSSSCG00000019010 | -- | −14.3 | 1.6 x 10-5 | 3.0 x 10-3 | snRNA |
| ENSSSCG00000000044 | C22orf32 | −3.8 | 1.8 x 10-5 | 3.0 x 10-3 | protein_coding |
| ENSSSCG00000003891 | CYP4A11 | 2.1 | 3.2 x 10-5 | 1.0 x 10-2 | protein_coding |
| ENSSSCG00000016238 | -- | 3.1 | 3.5 x 10-5 | 1.0 x 10-2 | pseudogene |
| ENSSSCG00000011937 | MORC1 | 6.1 | 3.9 x 10-5 | 1.0 x 10-2 | protein_coding |
| ENSSSCG00000010487 | CYP2C19 | 2.1 | 5.1 x 10-5 | 1.0 x 10-2 | protein_coding |
| ENSSSCG00000006614 | THEM5 | 18.0 | 1.4 x 10-4 | 2.0 x 10-2 | protein_coding |
| ENSSSCG00000005385 | NR4A3 | −2.7 | 1.4 x 10-4 | 2.0 x 10-2 | protein_coding |
| ENSSSCG00000006580 | S100A2 | −3.7 | 2.2 x 10-4 | 2.0 x 10-2 | protein_coding |
| ENSSSCG00000000231 | ANKRD33 | −2.6 | 3.0 x 10-4 | 3.0 x 10-2 | protein_coding |
| ENSSSCG00000001642 | TBCC | −14.3 | 3.2 x 10-4 | 3.0 x 10-2 | protein_coding |
| ENSSSCG00000003971 | -- | −2.0 | 3.3 x 10-4 | 3.0 x 10-2 | protein_coding |
| ENSSSCG00000015294 | CR1 | −2.0 | 3.7 x 10-4 | 3.0 x 10-2 | protein_coding |
| ENSSSCG00000006238 | CYP7A1 | 2.1 | 5.6 x 10-4 | 5.0 x 10-2 | protein_coding |
| ENSSSCG00000004789 | THBS1 | −1.7 | 6.0 x 10-4 | 5.0 x 10-2 | protein_coding |
| ENSSSCG00000012832 | MXRA5 | −2.1 | 6.5 x 10-4 | 5.0 x 10-2 | protein_coding |
| ENSSSCG00000004946 | ZWILCH | 2.2 | 6.7 x 10-4 | 5.0 x 10-2 | protein_coding |
| ENSSSCG00000007888 | TNFRSF17 | −3.7 | 6.7 x 10-4 | 5.0 x 10-2 | protein_coding |
| ENSSSCG00000008595 | APOB | 1.6 | 7.9 x 10-4 | 5.0 x 10-2 | protein_coding |
| ENSSSCG00000014919 | ME3 | −2.3 | 8.4 x 10-4 | 6.0 x 10-2 | protein_coding |
| ENSSSCG00000014368 | -- | −2.0 | 1.0 x 10-3 | 7.0 x 10-2 | protein_coding |
| ENSSSCG00000007529 | SYCP2L | 2.6 | 1.0 x 10-3 | 7.0 x 10-2 | protein_coding |
| ENSSSCG00000013116 | -- | 16.4 | 1.1 x 10-3 | 7.0 x 10-2 | protein_coding |
| ENSSSCG00000004052 | FNDC1 | −1.8 | 1.2 x 10-3 | 7.0 x 10-2 | protein_coding |
| ENSSSCG00000002277 | SPTB | −4.0 | 1.2 x 10-3 | 7.0 x 10-2 | protein_coding |
| ENSSSCG00000016645 | C7orf53 | −7.7 | 1.3 x 10-3 | 7.0 x 10-2 | protein_coding |
| ENSSSCG00000008203 | IGKV2-40 | −1.8 | 1.3 x 10-3 | 7.0 x 10-2 | protein_coding |
| ENSSSCG00000001229 | -- | −2.0 | 1.3 x 10-3 | 7.0 x 10-2 | protein_coding |
| ENSSSCG00000000151 | APOL6 | 3.4 | 1.5 x 10-3 | 8.0 x 10-2 | protein_coding |
| ENSSSCG00000004170 | -- | 2.2 | 1.9 x 10-3 | 8.0 x 10-2 | pseudogene |
| ENSSSCG00000016190 | SLC11A1 | −3.8 | 1.9 x 10-3 | 8.0 x 10-2 | protein_coding |
| ENSSSCG00000006355 | APOA2 | 1.8 | 1.9 x 10-3 | 8.0 x 10-2 | protein_coding |
| ENSSSCG00000015747 | MYOM2 | 2.8 | 2.3 x 10-3 | 9.0 x 10-2 | protein_coding |
| ENSSSCG00000014824 | RELT | −12.5 | 2.7 x 10-3 | 9.0 x 10-2 | protein_coding |
| ENSSSCG00000008455 | ABCG8 | 17.1 | 2.7 x 10-3 | 9.0 x 10-2 | protein_coding |
| ENSSSCG00000003777 | SLC44A5 | 2.6 | 2.8 x 10-3 | 9.0 x 10-2 | protein_coding |
| ENSSSCG00000003999 | A1BG | −5.9 | 2.8 x 10-3 | 9.0 x 10-2 | protein_coding |
| ENSSSCG00000002375 | RPS6KL1 | −2.2 | 3.2 x 10-3 | 1.3 x 10-1 | protein_coding |
| ENSSSCG00000001006 | TUBB2B | −2.9 | 3.4 x 10-3 | 1.4 x 10-1 | protein_coding |
| ENSSSCG00000007478 | ATP9A | −1.8 | 3.5 x 10-3 | 1.4 x 10-1 | protein_coding |
| ENSSSCG00000009992 | UQCR10 | 1.8 | 3.9 x 10-3 | 1.6 x 10-1 | protein_coding |
| ENSSSCG00000010829 | MOSC1 | 1.7 | 4.0 x 10-3 | 1.6 x 10-1 | protein_coding |
| ENSSSCG00000017923 | ALOX15 | −3.0 | 4.3 x 10-3 | 1.6 x 10-1 | protein_coding |
| ENSSSCG00000002847 | GPT2 | 1.7 | 4.6 x 10-3 | 1.7 x 10-1 | protein_coding |
| ENSSSCG00000004787 | GPR176 | 3.0 | 4.7 x 10-3 | 1.7 x 10-1 | protein_coding |
| ENSSSCG00000006985 | MTMR7 | 1.7 | 4.8 x 10-3 | 1.7 x 10-1 | protein_coding |
| ENSSSCG00000000709 | PLEKHG6 | −1.9 | 5.0 x 10-3 | 1.7 x 10-1 | protein_coding |
| ENSSSCG00000010892 | KCNT2 | 2.0 | 5.0 x 10-3 | 1.7 x 10-1 | protein_coding |
| ENSSSCG00000008624 | LPIN1 | 1.6 | 5.0 x 10-3 | 1.7 x 10-1 | protein_coding |
Differentially-expressed genes previously reported to be associated with the profile of intramuscular fatty acid composition in a genome-wide association study
| ENSSSCG00000004789 | 1 | 138129409 | 138145238 | THBS1 | C18:1(n-9), C18:2(n-6), MUFA |
| ENSSSCG00000008595 | 3 | 109052838 | 109076900 | APOB | C16:1(n-7), ratio C16:1(n-7)/c16:0 |
| ENSSSCG00000006238 | 4 | 77173363 | 77202771 | CYP7A1 | C16:1(n-7), C18:2(n-6) |
| ENSSSCG00000006355 | 4 | 92745976 | 92747590 | APOA2 | C16:0, C18:2(n-6), rate MUFA/SFA |
| ENSSSCG00000006614 | 4 | 101212520 | 101222091 | THEM5 | rate MUFA/SFA |
| ENSSSCG00000014919 | 9 | 20546397 | 20647476 | ME3 | rate C20:1/C20:0 |
1 The genomic coordinates are expressed in bp and are relative to the Sus scrofa April 2009 genome sequence assembly (Sscrofa9).
Description of the top seven molecular and cellular biological functions significantly modulated in the liver tissue when comparing H relative to L animals
| Lipid Metabolism | 1.15x10 -7 | |
| Small Molecule Biochemistry | 1.15x10 -7 | |
| Molecular Transport | 2.62x10 -6 | |
| Drug Metabolism | 7.20x10 -6 | |
| Energy Production | 7.20x10 -6 | |
| Nucleic Acid Metabolism | 5.85x10 -6 | |
| Vitamin and Mineral Metabolism | 8.65x10 -6 |
Statistical significance of pathway modulation was calculated via a right-tailed Fisher’s Exact test in Ingenuity Pathway and represented as –log (P value): -log values exceeding 1.30 were significant false discovery rate (FDR) < 0.05.
Figure 4Canonical pathway significantly detected when contrasting the up (red) and (green) down-regulated genes in H compared to L group. X-axis values are the log(B-H correction p-value) and Y-axis values are the canonical pathways. The statistical significance of pathway modulation was calculated via a right-tailed Fisher’s Exact test in Ingenuity Pathway analysis and represented as –log (P value): -log values exceeding 1.30 were significant false discovery rate (FDR) <0.05).
Description of the top six canonical pathways significantly modulated in liver tissue when comparing H to L animals
| LPS/IL-1 Mediated Inhibition of RXR Function | |
| Arachidonic Acid Metabolism | |
| Fatty Acid Metabolism | |
| PXR/RXR Activation | |
| Linoleic Acid Metabolism | |
| FXR/RXR Activation |
Statistical significance of pathway modulation was calculated via a right-tailed Fisher’s Exact test in Ingenuity Pathway analysis and represented as –log (P value): -log values exceeding 1.30 were significant FDR <0.05.
Figure 5Network 1 as generated by IPA. The significant biological functions comprising this network are lipid metabolism, small molecule biochemistry and vitamin and mineral metabolism. The network is displayed graphically as nodes (gene/gene products) and edges (the biological relationship between nodes). The node colour indicates the expression of genes: (red) up-regulated and (green) down-regulated in H group relative to L group. The shapes of nodes indicate the functional classes of the gene products. Relevant canonical pathways that feature modulated genes were indicted as well (e.g. Arachidonic Acid metabolism, PPARα/RXRα and PXR/RXR Activation).
Figure 6Graphical representation of the three merged networks generated by IPA. Depicted is the result of merging the network 1 (lipid Metabolism, Small Molecule Biochemistry and Vitamin and Mineral Metabolism), network 2 (lipid Metabolism, Molecular Transport and Small Molecule Biochemistry) and network 3 (carbohydrate Metabolism, Lipid Metabolism and Molecular Transport). The overrepresented canonical pathways such as Arachidonic and Linoleic Acid metabolism, PPARα/RXRα and FXR/RXR Activation are overlaid onto the resulting network, to show which genes are directly involved in these significant processes. Genes and gene products are represented as nodes and the relationship among these is represented as a line. Red indicates Up-regulated and green Down-regulated expression of genes when comparing H to L groups.